Odds and Socks Day

Yesterday our team at Harness Therapeutics stepped up in style for Odds And Socks Day in support of the Huntington's Disease Association!

Huntington's disease is a devasting genetic condition with a 50:50 chance of inheritance. At Harness Therapeutics, we are dedicated to transforming treatment with our lead FAN1 program, which targets the root cause to slow disease progression.

A huge thank you to everyone at Harness who participated by sporting their wildest sock combinations and contributing to our fundraising goal, raising an incredible £150! Your enthusiasm and generosity help make a difference in supporting families impacted by Huntington's disease.

#OddsAndSocksDay #WhatAreTheOdds #Harness #Biotech #HuntingtonsDisease #Neurodegenerativediseases

Our programmes

Huntington's Disease

Discover more

ALS and Alzheimer's

Discover more

Our news

June 2025

Harness Therapeutics Publishes HTT CAG Repeat Sizing Methodology Code on GitHub

February 2025

Harness Therapeutics to Present Nanopore Sequencing Data for Detecting CAG Expansion in the Huntingtin Gene at CHDI Huntington’s Disease Therapeutics Conference

January 2025

Harness Therapeutics appoints Dr Heather Preston as Chair and secures new funding from Ono Venture Investment to accelerate delivery of transformational neurodegeneration pipeline

September 2024

Harness Therapeutics Appoints Experienced R&D Executive and Physician-Scientist, Dr Paulo Fontoura, as Non-Executive Director

View all